Drugs & TargetsFree FDA grants fast track designation to Can-Fite BioPharma Ltd.’s liver cancer drug September 18, 2015Vol.41 No.34
FreeIn Brief Jones, Parwani Recruited to Key Roles in Ohio State Wexner Pathology Programs September 18, 2015Vol.41 No.34
Free NCI Funds Five Teams To Work With Animal Models for Children’s Cancer September 18, 2015Vol.41 No.34
Free Robert Califf Tapped for FDA Commissioner Position September 18, 2015Vol.41 No.34By Paul Goldberg
FreeIn Brief MD Anderson and Esperance Pharmaceuticals enter strategic alliance September 18, 2015Vol.41 No.34
Free Lowy: Increase for Cancer Center Grants Is Contingent on FY2016 Appropriations September 18, 2015Vol.41 No.34
FreeIn Brief Robin Davisson named president and CEO-elect of Melanoma Research Alliance September 18, 2015Vol.41 No.34
Free Bypass Budget Calls for 7% More in 2017—and Doubling by 2026 September 18, 2015Vol.41 No.34By Paul Goldberg
FreeIn Brief Broad Institute, MD Anderson Cancer Center designated as Genome Characterization Centers September 18, 2015Vol.41 No.34
